Maximilian J. Hochmair

Researcher Next ID · RN-008115

Researcher · Medicine

St. Pölten, Austria

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Research Studies

Lung Cancer Treatments and Mutations

Neuroendocrine Tumor Research Advances

Peptidase Inhibition and Analysis

Lung Cancer Diagnosis and Treatment

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.03136
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32222-6
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32222-6
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1801005
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1809064

No projects listed.